Abstract
After lung cancer, breast cancer (BC) is the second most frequent malignancy in women globally. Surgery followed by chemotherapy is the conventional treatment plan for BC. However, both are unsuccessful in treating BC because of the harmful effects that these treatments have on healthy tissues and organs. Many polymeric nanoparticles (PNPs) have been discovered and created recently to selectively aim cancer cells without harming normal cells. As an outcome, drug delivery systems (DDS) mediated by NPs have developed as a possible method to treat BC. PNPs have several special qualities that make them ideal for cancer treatment due to their tunable surface functions and choosiness to target tumor cells and minimize side effects
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
